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ABSTRACT 
Objective: The aim of this work was to formulate and evaluate orally disintegrating tablets of cinnarizine that were prepared by direct compression 
method using different types of diluents and super disintegrants. The rationale behind this work was to accelerate the disintegration of the tablet to 
provide rapid dissolution, quick action and enhanced bioavailability of the drug. 
Methods: The tablets were prepared by direct compression method using different types of diluents as mannitol, microcrystalline cellulose (MCC), 
and lactose. Different super disintegrants were used such as crospovidone (CP), sodium starch glycolate (SSG) and Kyron T-314; Kyron T-314 was 
used in different concentrations of 5%, 6%, 7%, and 8%. The prepared formulae (F1-F9c) were subjected to flowability studies and post-
compression evaluation studies. The optimized formula was selected depending on the time of disintegration and dissolution; then it was subjected 
to drug-excipient compatibility study and stability study. 
Results: Flowability results were ranging from excellent, excellent to good, and good to fair according to the type of the diluent used. All of the 
prepared tablets showed acceptable hardness, friability, drug content, and disintegration. A rapid disintegration of 11.66±2.25 s with the highest 
percentage 2 min-drug release of 74.55±3.01% was obtained by using the diluent lactose and the super disintegrant Kyron T-314 (8%) in the 
formula F9c. The infrared spectroscopic studies of the formula F9c showed no drug-excipient interaction. In addition, the stability study indicated 
that the optimized formula is a stable formula. 
Conclusion: Formula F9c of a rapidly disintegrating tablet was easy to be manufactured, and the results showed that this formula had a rapid 
disintegration, high dissolution profile, no noticeable chemical incompatibility and it was stable upon storage.  
Keywords: Orally disintegrating tablets, Super disintegrants, Cinnarizine, Direct compression 




Over the last decade, the development of orally disintegrating tablets 
(ODTs) has received increased interest among pharmaceutical 
industries and researchers [1]. Such dosage form is not only preferable 
for elderly and children, but also for adults consumers who like to 
have their medication obtainable at any time [2]. 
Orodispersible tablets are defined according to European 
Pharmacopoeia as “uncoated tablets intended to be placed in the 
mouth where they disperse rapidly before being swallowed” [3]. 
ODTs are also known as rapid dissolve, fast melting, quick 
disintegrating, fast dispersing, and/or rapid melt tablets [4]. After 
being disintegrated in saliva, ODTs produce a solution or suspension 
that can be swallowed easily by the patient [5]. It means that this 
dosage form mixes the advantages of both liquid and solid 
formulations. Also, the opportunity for pregastric absorption of the 
drug may increases as the drug passes through the mouth, pharynx, 
and esophagus toward the stomach. In such case bioavailability of 
the drug is significantly improved when compared with that of the 
conventional tablets [6]. 
Direct compression can be regarded as the easiest, most 
appropriate, and simplest way to obtain a rapidly disintegrating 
tablet with adequate structural integrity. In the direct compression 
method, the most important factor to be taken in concern is the 
selection of suitable excipients with good disintegration properties 
and compatibility. Several factors should be considered in selecting 
the super disintegrants because these agents do not affect the rate of 
disintegration only, but they also affect friability, hardness and how 
the tablet feels in the mouth. The disintegration and dissolution 
properties of the direct compressible ODTs are based on the single 
or combined action of disintegrants and water-soluble excipients. 
However, the disintegrants have the major role. Choosing of a 
suitable disintegrant type and in optimal concentration is essential 
for ensuring high disintegration rate [7]. 
Cinnarizine is histamine H1
Preparation of cinnarizine ODTs with enhanced disintegration and 
dissolution rate is beneficial because diseases like motion sickness, 
nausea and vomiting require immediate release of the drug from the 
dosage form. In addition, cinnarizine ODTs may improve patient 
compliance and reduce the side effect of the drug
-receptor blocker and voltage-gated 
calcium channel blocker used for the treatment of vertigo, Meniere’s 
disease, motion sickness, nausea, vomiting, and other symptoms of 
vestibular origin [8]. The drug is tasteless and water-insoluble [9]; 
therefore it can be considered as a model drug to be formulated as 
ODTs. Pharmaceutically, it belongs to the biopharmaceutical 
classification system (BCS) class II, and drug dissolution is the 
limiting step for its absorption [10]. 
.
MATERIALS AND METHODS 
 The aim of the 
present work was to formulate cinnarizine orally disintegrating tablets 
by direct compression method, to ensure that high percentage of the 
drug can be dissolved in the stomach within a short period of time 
which increases the opportunity for high bioavailability of the drug.  
Materials 
Cinnarizine powder was purchased from Apollo Healthcare Resources, 
Singapore. Lactose, Super Tab® 40LL was provided by DFE pharma, 
Germany. Microcrystalline cellulose PH 102 was taken from JRS 
pharma, US. Pearlitol, mannitol (400) DC was purchased from 
Roquette Pharma, French. Kyron T-314 was obtained from COREL 
PHARMA CHEM, India. Crospovidone (CP), sodium starch glycolate 
(SSG), sodium saccharin, citric acid anhydrous, talc, and magnesium 
stearate were supplied from Awamedica Drug Industries, Iraq. 
Preparation of cinnarizine ODTs by direct compression method 
using different types of super disintegrants 
Twelve different formulae of orally disintegrating tablets of cinnarizine 
(25 mg) were prepared by direct compression method using three 
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different types of diluents and three different types of super 
disintegrants as demonstrated in table 1. Sodium saccharine and citric 
acid were added to mask any unacceptable taste while magnesium 
stearate and talc were added as lubricant and glidant respectively. All the 
ingredients were passed through a sieve (mesh # 60) and blended 
thoroughly for 10 min, except talc and magnesium stearate which were 
added later and blended for further 2-3 min. The powder blend was 
compressed in tablets using 8 mm normal flat punches to get tablets of 
180 mg weight using multi-rotary tablet compression machine (Mini 
press II MT tablet compression, Rimek, India). 
 
Table 1: Composition of cinnarizine (25 mg) ODTs with a total weight of 180 mg 
Ingredients % (w/w) F1 F2 F3 F4 F5 F6 F7 F8 F9 F9a F9b F9c 
Cinnarizine 13.9 13.9 13.9 13.9 13.9 13.9 13.9 13.9 13.9 13.9 13.9 13.9 
Pearlitol, mannitol (400) DC 79.1 78.1 77.1 - - - - - - - - - 
MCC PH 102 - - - 79.1 78.1 77.1 - - - - - - 
Lactose, Super Tab® 40LL - - - - - - 79.1 78.1 77.1 76.1 75.1 74.1 
CP 3 - - 3 - - 3 - - - - - 
SSG - 4 - - 4 - - 4 - - - - 
Kyron–T314 - - 5 - - 5 - - 5 6 7 8 
Sodium saccharin 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Citric acid 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Magnesium-stearate 1 1 1 1 1 1 1 1 1 1 1 1 
Talc 2 2 2 2 2 2 2 2 2 2 2 2 
Total weight% (w/w)180 mg 100 100 100 100 100 100 100 100 100 100 100 100 
*w/w: Percentage by weight  
 
Flowability study of the prepared powder mixtures 
Measuring of the angle of repose 
The angle of repose is a characteristic related to inter-particulate 
friction or resistance to movement between particles [11]. It was 
determined using fixed height funnel method by measuring the 
height of the cone and the base formed by the powder falling 
through a funnel. It is calculated by applying the following equation:  




Where 𝜃𝜃 °= Angle of repose; h= height of powder cone; r= radius of 
powder cone. 
Compressibility index (Carr’s Index) and Hausner’s ratio 
“Compressibility is the measure obtained from the shrinkage of the 
apparent volume for a defined mass of powder after the 
rearrangement of the grains/particles during the application of 
tapping”[12]. Compressibility index (Carr’s Index) and Hausner’s 
ratio were determined by gently loading a certain amount of the 
powder through a funnel into 100 ml cylinder, and tapped until the 
volume stopped changing. Carr’s index and Hausner’s ratio were 
calculated according to the equation below:  
Carr’s index = V ° − Vf
V °
×  100, Hausner’s ratio = V °
Vf
 
Where v °= untapped apparent volume in ml, vf
Evaluation of the prepared cinnarizine tablets 
 = taped volume of 
blend in ml. 
Hardness (Crushing strength) 
Hardness test was done to determine the resistance of a tablet to the 
mechanical shocks during handling, shipping, storage, and 
transportation [13]. It was measured by tablet breaking force tester-
USP (Electrolab, India) and expressed in Newton (N). 
Friability (Resistance to abrasion) 
Friability test can be done to evaluate the ability of the tablets to 
withstand abrasion in packing, handling and transporting. Twenty 
tablets are randomly taken, dedusted, weighed accurately and 
transferred into friability tester-1 (EF-2, Electrolab, India). After 100 
rotations, the tablets were dedusted and weighed again, the friability 




W(initial) ×  100 
Uniformity of weight 
Twenty tablets were selected at random, and the average weight 
was calculated. The variation of the weight of the individual tablet 
from the average weight was calculated. In this work, the percentage 
limits allowed of weight variation according to the average weight of 
the tablets is 7.5% [3]. 
Disintegration test 
Disintegration time for cinnarizine ODTs was determined by 
disintegration tester-3 USP, (Electrolab, India), using 900 ml of 
distilled water, at 37 °C±0.5 [3]. The time needed for complete 
disintegration of the tablet with no palpable mass remaining in the 
apparatus was measured in seconds [15]. The disintegration time 
was also measured for the marketed cinnarizine conventional tablet 
(Stugeron® 25 mg tablet) as a reference.  
Wetting time 
The wetting time was measured using a simple procedure in which 
five circular tissue papers of 10 cm in diameter were placed in a 10 
cm circular petri dish. 10 ml solution of a water-soluble dye (0.02% 
tartrazine dye) was added. A tablet was carefully placed on the 
surface of the tissue paper, the time spent for water to reach the 
upper surface of the tablet represents the wetting time [16]. 
Water absorption ratio 
To measure the water absorption ratio, the same procedure as that 
of wetting time was followed. The initial weight of the tablet before 
placing it in the petri dish was recorded (Wb), the wetted tablet was 
taken and reweighed (Wa
Where R= water absorption ratio; W
). water absorption ratio (R) was 




×  100 
a= weight of the tablet after 
absorption; Wb
Dissolution test (In vitro drug release) 
= weight of the tablet before absorption. 
Dissolution test for the prepared ODTs of cinnarizine was performed 
using a dissolution test apparatus II (Pharma test, PT-DT7, 
Germany) with a paddle stirrer. A volume of 900 ml of 0.1 N HCl (pH 
1.2) was used as a dissolution medium at a speed of 50 rpm and a 
temperature of 37 °C±0.5. A sample of 5 ml of the medium was 
withdrawn at the predetermined time interval and replaced by the 
same volume of fresh drug-free dissolution medium. The samples 
were filtered through a 0.45 µm filter, diluted and analyzed at 254 
nm by UV spectrophotometer (Specord 40, analytic Jena, Germany), 
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the drug concentration was calculated from the calibration curve 
[15]. In addition, the dissolution test was conducted for the 
conventional cinnarizine tablet (Stugeron® 25 mg tablet) as a 
reference using the same procedure and conditions as that for the 
prepared ODTs of cinnarizine. 
Drug content (assay) 
From each formula of the prepared cinnarizine ODTs, 10 tablets 
were randomly selected and powdered. An equivalent amount of 25 
mg of cinnarizine was taken and dissolved in 0.1 N HCl, filtered and 
analyzed for drug content at the ƛ max (254) by UV -visible 
spectrophotometer [17]. 
Fourier transforms infrared (FTIR) studies 
Fourier transforms infrared (FTIR) spectra of cinnarizine alone, and 
mixtures of 1:0.57 of cinnarizine with Kyron, and 1:5.3 of cinnarizine 
with lactose (which represented the actual ratio of the constituent of 
the formula F9c), were recorded to detect any possible interaction 
between cinnarizine and other excipients. IR-spectrophotometer 
(Thermo Mattson IR 300, USA) was used with potassium bromide 
disc; the scanning range was 500-4000 cm-1
RESULTS AND DISCUSSION 
[18]. 
Stability study 
The selected ODTs formula (formula F9c) was subjected to 
accelerated stability study for three months at 40 °C in a stability 
chamber (Newtronic, India) with 75%±5 relative humidity (RH). In 
addition stability at 25 °C with 60±5 relative humidity (RH) for three 
months was conducted where samples were withdrawn every 
month and evaluated [19]. 
Statistical analysis 
The software Excel 2013 using t-test and ANOVA was used for 
statistical analysis, the difference was considered to be statistically 
significant when P<0.05 and non-significant when P>0.05. Mean, and 
standard deviation was used to express the values in the data. 
Flowability study of the prepared powder mixtures 
The results of the flowability study showed that those formulae that 
were prepared using mannitol as a diluent (F1, F2, and F3) had 
excellent flow properties. The angle of repose was in the range of 
(24.98±0.36 to 28.319±1.52), Carr’s index was less than 10%, and 
Hausner’s ratio was less than 1.11. This was due to the free-flowing 
nature of the granulated form of mannitol (Perlitol 300 DC) [20]. 
The formulae that were prepared with MCC diluent (F4, F5, and F6) 
showed flow properties ranged from good to fair. The angle of repose 
was in the range of (34.43±0.14 to 40.44±3.70), Carr’s index was in the 
range of (10.69±0.887% to 16.39±0.27%), and Hausner’s ratio was in 
the range of (1.11±0.015 to 1.195±0.005) because MCC is made up of 
crystalline powder that is porous in nature with a low bulk density 
which hinders its flowability [21]. The formulae (F7, F8, and F9) that 
were prepared with the diluent lactose (super Tab® 40LL) showed good 
to excellent flow properties, the angle of repose was in the range of 
(24.83±2.19 to 34.4±0.43), Carr’s index was in the range of (6.37±0.94% 
to 14.49±0.054%) and Hausner’s ratio was in the range of (1.065±0.007 
to 1.1694±0.021) due to the presence of lactitol monohydrate in its 
composition which enhanced its flow properties [22]. 
Evaluation of cinnarizine orally disintegrating tablets 
The hardness of the tablets from all of the formulae was within an 
acceptable range (21.97±1.76 N to 31.55±4.40 N). The highest 
hardness value was observed for the formulae F4, F5, and F6 due to 
the strong inter-particle force between MCC particles [7]. In addition 
to the acceptable friability of less than 1%. Tablets thickness was in 
the range of (2.88±0.03 mm to 2.97±0.02 mm), except for the 
formulae F4, F5, and F6, in which higher thickness range was 
reported (3.46±0.02 mm to 3.59±0.07 mm), due to the low bulk 
density of MCC that was used as a diluent for them [21]. The weight 
variation was acceptable and within the pharmacopoeial limits, and 
the drug content was found to be good and not less than 90% or 
more than 110% which is the required limit [3]. 
Disintegration time 
The disintegration time was in the range of (4.33±1.53s to 
28.02±7.1s) as shown in table 2. The formulae F5 and F6 that were 
prepared with the diluent MCC showed the shortest disintegration 
time which may be due to the self-disintegration property of MCC (it 
disintegrate by capillary and swelling mechanism) which was 
complimentary with the disintegration properties of the super 
disintegrants that were used [23]. Lactose showed shorter 
disintegration time than mannitol which may be attributed to the 
reported spontaneous disintegration property of lactose [24]. 
Coming to the effect of the super disintegrant on disintegration time, 
CP revealed the shortest disintegration time among the other super 
disintegrants in the formulae that were prepared with mannitol (F1, 
F2, and F3), (ANOVA, *P<0.05) and lactose (F7, F8, and F9), (ANOVA, 
**P<0.01). The order of the disintegration time in such formulae was 
found to be CP>Kyron T-314>SSG. CP with its porous structure 
quickly absorbs water into the tablet by capillary action followed by 
secondary swelling which results in rapid disintegration of the tablet 
[25]. Kyron disintegrates evenly by wicking mechanism mainly, also 
by swelling on hydration [26]. SSG disintegrates by swelling, but 
unlike CP and Kyron T-314, it gels at a high level which may result in 
the formation of a thick viscous barrier that retards disintegration 
[27]. These results are in agreement with the results obtained by 
Swatantra et al. (2014), in a comparative study on the effect of 
various super disintegrants in the formulation of ibuprofen fast 
dissolving tablets [28]. 
Conversely, the formulae that were prepared with the diluent MCC; 
CP revealed the longest disintegration time in the formula F4 
compared with that of F5 and F6. It may be due to the lower water 
absorption ratio of the formula F4 with this super disintegrant when 
compared with that of SSG and Kyron T-314 (F5 and F6) as shown in 
table 2. 
Wetting time 
Wetting time can be regarded as one of the vital parameters to 
predict how much of the fluid is enough for breaking the tablet when 
placed upon the tongue (fig. 1). All of the tested formulae were 
wetted within an acceptable time of less than one minute as 
illustrated in table 2, which indicated their ability to absorb water 
and swell. The results were in the range of 2.72±0.75s to 43.64±6.4s. 
The shortest wetting time was with the formulae that were prepared 
with MCC (F4, F5, and F6 with the wetting time of 10.03±3.01s, 
4.62±0.68s, and 2.72±0.75s respectively), this could be due to its 
porous structure [21]. 
The type of the super disintegrant had a significant effect on wetting 
time in the formulae F4, F5, and F6 that were prepared with the 
diluent MCC. Like the disintegration time, the formula F4 that was 
prepared with the super disintegrant CP showed the longest wetting 
time (10.03±3.01s) compared with those prepared with SSG and 
Kyron-T314 (4.62±0.68s and 2.72±0.75s) respectively (ANOVA, 
*P<0.05).  
Water absorption ratio 
The highest water absorption ratio was observed for the 
formulae that were prepared with MCC, followed by those 
prepared with lactose then mannitol, as illustrated in table 2. 
The effect of the super disintegrant on water absorption ratio 
appeared when MCC was used as a diluent. The super 
disintegrant SSG significantly increased the water absorption 
ratio from 115.27±5.68% and 182.49±13.75% when CP and 
Kyron T-314 were used as super disintegrants to 232.39±8.62% 
which may lead to less patient compliance due to the long stay 
on the tongue (ANOVA, **P<0.01). These results are in 
agreement with the results obtained by Lakshmi et al. (2013) 
who made a comparative evaluation of natural and synthetic 
superdisintegrants in the formulation of fast dissolving tablets 
[29]. Moreover, when the concentration of Kyron T-314 
increased from 5% in the formula F9 to 8% in formula F9c, the 
water absorption ratio increased from 58.52±0.51% to 
81.45±7.04% (ANOVA, *P<0.05), while the disintegration and 
wetting time were not significantly affected. 
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(A)     (B)     (C) 
Fig. 1: The morphological changes of the prepared ODTs of cinnarizine (formula F9c) during wetting time test, (A) at time zero, (B) during 
wetting, (C) after complete wetting (17.75s). n=3 
 
Dissolution test 
The ODTs of cinnarizine were subjected to the dissolution test using 
0.1N HCl (pH=1.2) as a dissolution medium. The release data 
obtained through the dissolution study is shown in table 2. The 
release profiles in fig. 2, fig. 3, and fig. 4 demonstrated that among 
the different types of diluents, lactose revealed the highest 
percentage of the drug released that reached up to 61.46±4.60% in 
the formula F9 after 2 min. The reason may be related to the high 
water solubility of the type of lactose that was used in this work 
(SuperTab®
In fact, the type of the super disintegrants had no significant effect 
on the percentage of the drug released in the formulae that were 
prepared with the diluent mannitol (F1, F2, and F3) (fig. 5). While 
the super disintegrant Kyron T-314 significantly increased the 
percentage of the drug released in the formula F6 that was prepared 
with the diluent MCC, (51.24±8.34% after 2 min) when compared 
with the other formulae with this type of diluent (F4 and F5), (fig. 6), 
(ANOVA, **P<0.01). Similarly, in the formulae that were prepared 
with the diluent lactose, the super disintegrant Kyron T-314 
revealed the highest percentage of the drug released (61.46±4.60% 
after 2 min in the formula F9) among the formulae that were 
prepared with lactose (ANOVA, **P<0.01) and all other formulae 
(F1-F9), (fig. 7). 
 40LL) when compared with the others. It was composed 
of anhydrous lactose and lactitol monohydrate, the dissolution rate 
of anhydrous β-lactose is 10 times more than that of α-lactose 
monohydrate [30], while MCC is practically insoluble in water [31]. 
Kyron T-314 increased the porosity of cinnarizine 
tablets due to which the absorption of water takes place at a higher 
rate that results in breaking of the tablets and therefore faster 
disintegration/dissolution [32]. 
By increasing the percentage of Kyron-T314 from 5% in the formula, 
F9 to 8% in the formula F9c the percentage of the drug release dafter 2 
min increased from 61.46±4.60 to 74.55±3.0 (fig. 8), (ANOVA, 
**P<0.01). These results were much higher than that of the 
commercially available cinnarizine tablets (Stugeron® 25 mg tablet), 
in which only 8.75±2.15% of the drug was released within 2 min. 
These results are in agreement with 
the results obtained by Gattu and Lakshmi (2011), who made a 
comparative evaluation of natural and synthetic super-disintegrants 
with newer superdisintegrant Kyron T-314 [33].  
Results of the release kinetic models showed that all of the formulae 
followed the first order kinetics. The k1 
 
value increased in all of the 
formulae with increasing of the percentage of the drug released (table 2). 
From the above results, formula F9c can be selected as the most 
appropriate formula that showed rapid disintegration (11.66±2.25 s) 
when compared with that of the marketed one (312±4.32 s), (t-test, 
**P<0.01), with the highest dissolution profile among the other formulae. 
 
Fig. 2: Percentage release of cinnarizine from the prepared ODTs 
with different types of diluents in the presence of the super 
disintegrant (crospovidone). n=6; Data are expressed as mean±SD
 







Water Abs -orption ratio 
after 10 s (s) **
Drug content
 (%)  
** Drug released after 






F1 8.33±0.57 21.23±7.1 31.81±2.04 92.43±0.38 45.63±5.86 0.3047 
F2 28.02±7.1 43.64±6.41 15.95±0.169 90.42±0.30 40.07±5.25 0.2560 
F3 16.10±3.60 34.67±7.70 20.74±1.41 90.03±0.03 45.77±5.86 0.3060 
F4 12.33±1.53 10.03±3.01 115.27±5.68 90.06±0.02 22.69±4.01 0.1286 
F5 5.66±0.57 4.62±0.68 232.39±8.62 94.42±0.48 29.89±8.67 0.1775 
F6 4.33±1.53 2.72±0.75 182.49±13.75 93.13±1.10 51.24±8.34 0.3592 
F7 6.66±0.57 14.72±3.61 58.51±6.78 90.01±0.34 55.76±7.41 0.4078 
F8 15±2.65 22.24±5.71 49.97±3.39 92.38±0.08 45.83±7.82 0.3065 
F9 9.33±2.06  15.05±4.25 58.52±0.51 93.28±0.05 61.46±4.60 0.4768 
F9a 9.66±2.25  15.53±3.59 62.81±5.05 91.93±2.05 62.96±5.81 0.4966 
F9b 11±2  17.74±1.38 78.76±6.61 95.3±6.12 71.04±4.07 0.6197 
F9c 11.66±2.25  17.75±1.67 81.45±7.04 93.15±0.51 74.55±3.01 0.6843 
Stugeron® 25 mg 
tablet 
312±4.32 - - 92.29±1.40 8.75±2.15 - 
K1: First order release constant, *Average of six reading±SD, **Average of three reading±SD 
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Fig. 3: Percentage release of cinnarizine from the prepared 
ODTs with different types of diluents in the presence of the 
super disintegrant SSG. n=6; data are expressed mean±SD 
 
 
Fig. 4: Percentage release of cinnarizine from the prepared 
ODTs with different types of diluents in the presence of the 




Fig. 5: Percentage release of cinnarizine from ODTs prepared 
with different types of super disintegrants and mannitol 
diluent. n=6; Data are expressed as mean±SD 
 
Fourier transforms infrared (FTIR) studies 
The FTIR studies showed no detected chemical interaction between 
cinnarizine, Kyron T-314, and lactose. Fig. 9 shows that there were 
no noticed shift in peaks or extra peaks appeared when comparing 
IR of cinnarizine alone (fig. 9, a), lactose alone (fig. 9, b), Kyron T-
314 alone (fig. 9, c) with the IR chart of the physical mixture of 




Fig. 6: Percentage release of cinnarizine from ODTs prepared 
with different types of super disintegrants and MCC diluent. 
n=6; Data are expressed as mean±SD 
 
 
Fig. 7: Percentage release of cinnarizine from ODTs prepared 
with different types of super disintegrants and lactose diluent. 
n=6; Data are expressed as mean±SD 
 
 
Stug: Stugeron® 25 mg 
Fig. 8: Percentage release of cinnarizine from ODTs (F9, F9a, 
F9b, F9c), prepared with a different concentration of the super 
disintegrant (Kyron T-314), and from the marketed product, 
Stugeron® 25 mg. n=6; Data are expressed as mean±SD 
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(a)                                                                        (b) 
 
(c)                       (d) 
 
(e) 
Fig. 9: FTIR spectra of cinnarizine alone (a), lactose alone (b), Kyron T-314 alone (c), cinnarizine and lactose (d), cinnarizine and Kyron T-314 (e) 
 
Stability study 
The results of the stability study of the optimized formula (F9c) 
showed that there were no significant changes in hardness, 
friability, disintegration, drug release and drug content of the 
examined tablets through the stability study (table 3). The only 
exception is the noticed increase in weight that was observed for 
the tablets stored at 40 °C, 75%±5 RH which might be due to the 
hygroscopic nature of the anhydrous lactose that presents in the 
tested formula [34]. 
  
Table 3: Stability study data of ODTs of cinnarizine 
Days Stability conditions Drug content** Disintegration time (%) * (s) 
At time zero - 93.15±0.51 11.66±2.25 
30  25C ° and 60±5 RH 93.23±0.06 11.03±1.34 
40C ° and 75±5 RH 94.22±0.70 11.39±2.25 
60 25C ° and 60±5 RH 96.8±0.92 10.60±2.26 
40C ° and 75±5 RH 96.01±1.23 10.86±2.321 
90 25C ° and 60±5 RH 93.76±1.56 11.16±0.75 
40C ° and 75±5 RH 93.59±0.268 10.83±1.16 
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Owing to that cinnarizine is a class II drug according to the 
biopharmaceutical classification system (BCS), so any improvement 
in the dissolution will lead to enhancement of the bioavailability. It 
was successfully formulated as ODTs by using direct compression 
method. Among the various diluents used, lactose was selected. In 
addition, different super disintegrants were used, the super 
disintegrant Kyron T-314 was the most successful one when used 
with the diluent lactose. It played an important role in decreasing 
the disintegration time and enhancing the dissolution of the drug. 
The selected formula showed acceptable characteristics, rapid 
disintegration and dissolution, and good stability. Accordingly, the 
selected formula (F9c) represents a promising formula for preparing 
ODTs by using the simple, direct compression strategy. 
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